The accelerated growth of patient-centric trials is driven by innovations in remote patient monitoring (RPM) and precision medicine. Insider intelligence estimates that 70.6 million US patients, or 26.2% of the population, will use RPM tools by 2025.
With this growth comes new potential, as sponsors and CROs gain the ability to drive better patient outcomes, increase patient adherence, improve health metrics, and ensure seamless patient onboarding.
However, it takes more than simply adding tools to your trial to gain this insight: Join us on Thursday, November 10, 2022 as experts from Medable’s Digital Medicine and Partner Technologies area showcase: